| S.No | PRODUCT NAME | CAS NO | END STAGE |
| 1 | Citirizine di hydrochloride | ||
| A | P- chloro benzophenone | 134-85-0 | KSM-1 |
| B | P- chloro Benzhydryl chloride | 134-83-8 | Key intermediate |
| C | 1-(4-Chlorobenzhydryl)piperazine | 303-26-4 | Key intermediate |
| 2 | DIBUCAINE | ||
| A | 2-Hydroxy quinolone carboxylic acid | 15733-89-8 | Key intermediate |
| B | 4-Methylcarbostyril | 607-66-9 | Key intermediate |
| 3 | ATOMAXETINE | ||
| A | 3-chloro-N,N-Dimethyl-3-phenyl-1-propanamine.HCl | 79130-51-1 | Key intermediate |
| 4 | AZILSARTAN | ||
| A | Methyl 2-ethoxy-1-((2′-(N-hydroxycarbamimidoyl)-[1,1′-biphenyl]-4-yl) methyl)-1H-benzo[d]imidazole-7-carboxylate, | 147403-65-4 | Key intermediate |
| Methyl 2-ethoxy-1-((2′-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1′-biphenyl]-4-yl) methyl)-1H-benzo[d]imidazole-7-carboxylate | 147403-52-9 | Key intermediate | |
| 5 | APREMALAST | ||
| A | 3-ACETAMIDOPTHALIC ANHYDRIDE | 6296-53-3 | Key intermediate |
| 6 | CINACALCET | ||
| A | R-(+)-1-(1-Napthyl) ethyl Amine | 3886-70-2 | Key intermediate |
| B | R-(+)-1-(1-Napthyl) ethyl Amine Mandalate salt | 1073144-62-3 | Key intermediate |
| 7 | DHARUNAVIR | ||
| A | tert-Butyl [(1S,2R)-1-benzyl-2-hydroxy-3-[isobutyl[(4-nitrophenyl) sulfonyl] amino] propyl] carbamate | 191226-98-9 | Key intermediate |
| B | 4-AMINO-N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]-N-ISOBUTYLBENZENE-1-SULFONAMIDE | 169280-56-2 | Key intermediate |
| 8 | DULOXETINE | ||
| A | RS-N, N-Dimethyl-3-hydroxy-3-(2-thienyl)-1-propanamine | 13636-02-7 | Key intermediate |
| B | S (-)-N, N-Dimethyl-3-hydroxy-3-(2-thienyl)-1-propanamin | 132335-44-5 | Key intermediate |
| C | S-(+)-N, N-Dimethyl-3-(1-Naphthalenyloxy)-3-(2-thienyl)-1-propanamine oxalate | 132335-47-8 | Key intermediate |
| 9 | DABIGATRAN | ||
| A | N-(4-cyanophenyl) glycine | 42288-26-6 | Key intermediate |
| B | N((2(((4(aminoiminomethyl)phenyl) amino) methyl)-1-methyl-1H-benzimidazol-5-yl) carbonyl)-N-2-pyrimidinyl-β-alanineethyl ester hydrochloride salt | 211914-50-0 | Key intermediate |
| C | 3-[3-Amino-4-(methylamino)-N-(2-pyridyl) | 212322-56-0 | Key intermediate |
| benzamido] propionic Acid Ethyl Ester | |||
| D | 3-[[[2-[[(4-Cyanophenyl) amino] methyl]-1-methyl-1H-benzimidazol-5-yl] carbonyl] pyridin-2-ylamino] propionic acid ethyl ester | 211915-84-3 | Key intermediate |
| E | Ethyl 3-(pyridin-2-ylamino) propanoate | 103041-38-9 | Key intermediate |
| F | 3-Methyl-4-Amino-Benzoic acid | 66315-15-9 | Key intermediate |
| 10 | FINGOLIMOD | ||
| A | Diethyl acetamidomalonate | 1068-90-2 | Key intermediate |
| 11 | FAVIPIPRAVIR | ||
| A | 6-Bromo-3-Hydroxypyrazine-2-Carboxamide | 259793-88-9 | Key intermediate |
| B | 3-hydroxy pyrazine-2-carboxamide | 55321-99-8 | Key intermediate |
| 12 | IRBESARTAN | ||
| A | 2-n-Butyl-1,3-diazaspiro [4.4] non-1-en-4-one, 2-N-BUTYL-1,3-DIAZA-SPIRO [4,4] NON-1-EN-4-ONE HYDROCHLORIDE | 138402-05-8 | Key intermediate |
| 13 | LURASIDONE | ||
| A | (3aR,4S,7R,7aS)-rel-Hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione | 14805-29-9 | Key intermediate |
| B | 3-(1-Piperazinyl)-1,2-benzisothiazole | 87691-87-0 | Key intermediate |
| C | (R, R)-1,2-Bis(methanesulfonyloxymethyl)cyclohexane | 186204-35-3 | Key intermediate |
| 14 | MEMANTINE HYDROCHLORIDE | ||
| A | 1-Bromo-3,5-dimethyladamantane | 941-37-7 | Key intermediate |
| B | 1-Actamido-3,5-dimethyladmantane | 19982-07-1 | Key intermediate |
| 15 | MONTELUKAST | ||
| A | montelucastDicyclohexylamine salt | 577953-88-9 | N-1 |
| B | 2(1-(mercapto methyl)cyclo propyl)acetic acid | 162515-68-6 | Key intermediate |
| 16 | OMEPRAZOLE | ||
| A | OMEPRAZOLE SULPHIDE | 73590-85-9 | N-1 |
| 17 | REMDESIVIR | ||
| A | (3aR,5R,6R,6aR)-5-((R) 2,2 dimethyl-1,3-dioxolan-4-yl)-2,2-dimethyl tetrahydrofuro(2,3-d) (1,3) dioxol-6-ol | N/A | Key Rawmaterial |
| 18 | SILODOSIN | ||
| A | 2-(2-(2,2,2-trifluoroethoxy)-phenoxy)-ethyl methanesulfonate | 160969-03-9 | Key intermediate |
| B | 5-[(2R)-2-Aminopropyl]-2,3-dihydro-1-[3-(phenylmethoxy) propyl]-1H-indole-7-carbonitrile | 459868-73-6 | Key intermediate |
| 19 | TRAZODONE.HCl | ||
| A | Bis (2-chloroethyl) amine hydrochloride | 821-48-7 | Key intermediate |
| B | 1-(3-Chlorophenyl) piperazine hydrochloride | 13078-15-4 | Key intermediate |
| 20 | VERTIOXETINE | ||
| A | 2,4-Dimethylbenzene thiol | Key intermediate | |
| 21 | VERAPAMIL | ||
| A | Homoveratronitrile | 93-17-4 | Key intermediate |
| B | 3,4-Dimethoxyphenethylamine | 120-20-7 | Key intermediate |
| C | Isopropyl Veratronitrile | 20850-49-1 | Key intermediate |
| D | Homo Veratric Acid | 93-40-3 | Key intermediate |
| E | N-Methyl Homo veratryl amine Hydrochloride | 13078-76-7 | Key intermediate |
| 22 | VILAZODONE | ||
| Ethyl 5-amino-1-benzofuran-2-carboxylate | 174775-48-5 | Key intermediate | |
| 23 | 3,4 -Di hydroxy benzoic acid ethyl ester | N/A | KRM |